Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis.
Universal cervical length screening and treatment with vaginal progesterone to prevent preterm birth: a decision and economic analysis.
复制标题
DOI：
10.1016/j.ajog.2009.12.005
复制
发表时间：
2010-06
影响因子：
9.8
通讯作者：
Romero R
中科院分区：
文献类型：
--
作者：
Cahill AG;Odibo AO;Caughey AB;Stamilio DM;Hassan SS;Macones GA;Romero R
To estimate which strategy is the most cost-effective for prevention of preterm birth and associated morbidity. We used decision-analytic and cost-effectiveness analyses to estimate which of 4 strategies was superior based on quality-adjusted life-years (QALYs), cost in US dollars ($), and number of preterm births prevented. Universal sonographic screening for cervical length and treatment with vaginal progesterone was the most cost-effective strategy and dominant over 3 alternatives: cervical length screening for women at increased risk for preterm birth and treatment with vaginal progesterone; risk-based treatment with 17 α-hydroxyprogesterone Caproate (17-OHP-C) without screening; no screening or treatment. Universal screening represented savings of $1,339 ($8,325 vs. $9,664) when compared to treatment with 17-OHP-C, and led to a reduction of 95,920 preterm births annually in the US. Universal sonographic screening for short cervical length and treatment with vaginal progesterone appears cost-effective and yields the greatest reduction in preterm birth prior to 34 weeks.
登录
查看更多内容
DOI：
10.1016/s0002-9378(96)70225-9
发表时间：
1996-06-01
影响因子：
9.8
作者：
Mercer, BM;Goldenberg, RL;Roberts, J
通讯作者：
Roberts, J
影响因子：
7.1
作者：
Heath, VCF;Souka, AP;Nicolaides, KH
通讯作者：
Nicolaides, KH
DOI：
10.1016/s0002-9378(98)70544-7
发表时间：
1998-05-01
影响因子：
9.8
作者：
Iams, JD;Goldenberg, RL;Roberts, JM
通讯作者：
Roberts, JM
影响因子：
9.8
作者：
Hassan, SS;Romero, R;Wolfe, HH
通讯作者：
Wolfe, HH
影响因子：
158.5
作者：
LOCKWOOD, CJ;SENYEI, AE;GARITE, TJ
通讯作者：
GARITE, TJ